Harry-james Sutter

Title: Innovations of Harry-James Sutter in Antibody Purification

Introduction

Harry-James Sutter is a notable inventor located in Vevey, Switzerland. With two patents to his name, he has made significant contributions to the field of pharmaceutical compositions and antibody purification.

Latest Patents

His latest patents showcase advanced methods for purifying specific antibodies. One of his patents addresses a method for purifying anti-IL-6 receptor antibodies, involving a unique three-chromatographic column procedure. This method utilizes Fluorapatite-containing resin, allowing for the effective separation of antibodies from impurities. Additionally, this invention also encompasses pharmaceutical compositions consisting of the purified antibodies.

Sutter's other significant patent details a method for purifying adalimumab or its biosimilars from a sample that contains both the target antibodies and impurities. This method employs hydroxyapatite resin in a Bind/Elute mode, ensuring that the adalimumab binds effectively while leaving a portion of the impurities unbound. Similar to his previous invention, this patent also covers pharmaceutical compositions derived from the purified antibodies.

Career Highlights

Harry-James Sutter works with Fresenius Kabi Deutschland GmbH, a leading company in the development and production of specialty pharmaceuticals and medical devices. His work within this company has positioned him at the forefront of pharmaceutical innovation, particularly in biopharmaceutical production processes.

Collaborations

Sutter collaborates with esteemed colleagues such as Matteo Costioli and Hervé Broly. Their combined expertise and dedication to innovation play a crucial role in advancing the company's research and development efforts.

Conclusion

With his inventive methods for antibody purification, Harry-James Sutter has significantly impacted the pharmaceutical industry. His work not only improves the efficiency of antibody purification but also contributes to the production of essential biopharmaceuticals that can aid in the treatment of various diseases.